Classic Hodgkin Lymphoma — Trials

Classic Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 32.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–20 of 20 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06377540	MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma	recruiting	Phase 2	28	Masonic Cancer Center, University of MinnesotaOTHER	1	Sep 29, 2026	clinicaltrials
NCT04561206	Brentuximab Vedotin and Nivolumab for the Treatment of Patients With Relapsed/Refractory Classical Hodgkin Lymphoma	recruiting	Phase 2	31	City of Hope Medical CenterOTHER	1	Sep 22, 2026	clinicaltrials